-The Economic Times Pharma companies sponsoring clinical trials in India would now need to compensate volunteers in cases of trial-related deaths or injuries. Firms and clinical research organisations failing to pay up, could face suspension of trials and even a permanent ban. The decision to make compensation mandatory in such cases comes four weeks after the Supreme Court chided the government for its sloppy regulation of clinical trials. A senior government official said...
More »SEARCH RESULT
'Breast cancer survival rates low in rural India'
-PTI Washington: Early breast cancer diagnosis and survival rates are very low among women living in rural India compared to those in developed nations, a new study has claimed. Researchers said women in developed countries survive roughly 10 years longer after a breast cancer diagnosis compared to women in poor-to-middle-income countries. The study by University of Michigan demonstrates the lack of access to good health care faced by women in poor countries, said...
More »Pharma MNCs use RTI law to protect market for patented drugs & delay entry of generics
-The Economic Times Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive legal action against local generic players to protect the market of patented drugs and delay the entry of low cost generic medicines in the 60,000-crore domestic drug market. MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few months' window between the...
More »The great number fetish-Sankaran Krishna
-The Hindu One of the most prominent features of India’s middle-class-driven public culture has been an obsession about our GDP growth rate, and a facile equation of that number with a sense of national achievement or impending arrival into affluence. In media headlines, political speeches, and everyday conversations, the GDP growth rate number — whether it is five per cent or eight per cent or whatever — has become a staple...
More »No child left behind -Aarti Dhar
-The Hindu India’s polio triumph is a rare milestone in its uninspiring public health record. The story so far only strengthens the case for a vastly augmented routine immunisation programme to combat disease. India has been celebrating its near-victory over polio for the past two years, but it often hogs the headlines for unacceptably high mortality and morbidity due to other communicable diseases such as malaria, tuberculosis, dengue and filaria. The government now...
More »